Abstract
This Frost & Sullivan research service titled European Bladder Cancer Therapeutics Markets presents a concise analysis of the market that includes challenges, factors driving growth and the revenue forecasts from 2003 to 2013. The study identifies the competitive opportunities within the market as well as strategies to exploit these opportunities and overcome industry challenges. In this research, Frost & Sullivan' s expert analysts thoroughly examine the cytotoxic (chemotherapy therapies) and targeted therapies segments.
This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
Table of Contents
1 EXECUTIVE SUMMARY
- Overview
- Overview of the Bladder Cancer Therapeutics Market
2 GLOSSARY OF TERMS
- List of Terms
- Abbreviations
3 MARKET OVERVIEW
- Introduction
- Disease Characteristics
- Epidemiology
- Market Definitions and Segmentation
- Definitions
- Segmentation
4 RESEARCH METHODOLOGY AT FROST & SULLIVAN
- Research Objectives and Scope
- Research Methodology
5 INDUSTRY CHALLENGES
- Challenges for the Bladder Cancer Market
- Challenges Faced by Pharmaceutical Companies
6 TOTAL EUROPEAN MARKET FOR BLADDER CANCER THERAPEUTICS
- Overview and Defintions
- Introduction
- Market Drivers
- Market Restraints
- Current Therapeutic Options - Superficial Bladder Cancer
- Current Therapeutic Options - Invasive Bladder Cancer
- Future Therapeutic Approaches
- Current Treatment Guidelines
- Market Engineering Measurement Analysis
- Competitive Analysis
- Profiles of Key Industry Participants
- Market Share Analysis
- Pipeline Analysis
7 TOTAL FORECASTS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET
- Forecasts
- Patient Forecasts and Geographical Trends
- Market Revenue Forecasts
8 PRICING AND REIMBURSEMENT IN EUROPE
- Pricing and Reimbursement Issues
- Pricing and Reimbursement - Country Analysis
- Pricing and Reimbursement
9 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET
- Market Engineering Recommendations
- Strategic Recommendations
10 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Key Industry Participants
- Key Participants in the Bladder Cancer Therapeutics Market
11 DECISION SUPPORT DATABASES
- Habitual Indicators
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Prevalence of Smokers
- Healthcare Expenditure
- Expenditure
- Per Capita Healthcare Expenditure
- Cancer Incidence
- Bladder Cancer Incidence in Western Europe
- Bladder Cancer Incidence in Selected European Countries
- Cancer Mortality
- Bladder Cancer Mortality in Western Europe
- Bladder Cancer Mortality in Selected European Countries
